BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16956907)

  • 21. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.
    Kloth MT; Laughlin KK; Biscardi JS; Boerner JL; Parsons SJ; Silva CM
    J Biol Chem; 2003 Jan; 278(3):1671-9. PubMed ID: 12429742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.
    Brew CT; Aronchik I; Kosco K; McCammon J; Bjeldanes LF; Firestone GL
    Int J Cancer; 2009 May; 124(10):2294-302. PubMed ID: 19173291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.
    Nautiyal J; Yu Y; Aboukameel A; Kanwar SS; Das JK; Du J; Patel BB; Sarkar FH; Rishi AK; Mohammad RM; Majumdar AP
    Mol Cancer Ther; 2010 Jun; 9(6):1503-14. PubMed ID: 20515951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.
    Tiwari RK; Guo L; Bradlow HL; Telang NT; Osborne MP
    J Natl Cancer Inst; 1994 Jan; 86(2):126-31. PubMed ID: 8271295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter.
    Cram EJ; Liu BD; Bjeldanes LF; Firestone GL
    J Biol Chem; 2001 Jun; 276(25):22332-40. PubMed ID: 11297539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.
    De Santi M; Galluzzi L; Lucarini S; Paoletti MF; Fraternale A; Duranti A; De Marco C; Fanelli M; Zaffaroni N; Brandi G; Magnani M
    Breast Cancer Res; 2011 Mar; 13(2):R33. PubMed ID: 21435243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.
    Howells LM; Gallacher-Horley B; Houghton CE; Manson MM; Hudson EA
    Mol Cancer Ther; 2002 Nov; 1(13):1161-72. PubMed ID: 12479697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
    Takabatake D; Fujita T; Shien T; Kawasaki K; Taira N; Yoshitomi S; Takahashi H; Ishibe Y; Ogasawara Y; Doihara H
    Int J Cancer; 2007 Jan; 120(1):181-8. PubMed ID: 17036319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms, and subcellular localization of the CDK2 protein complex.
    Garcia HH; Brar GA; Nguyen DH; Bjeldanes LF; Firestone GL
    J Biol Chem; 2005 Mar; 280(10):8756-64. PubMed ID: 15611077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells.
    El-Daly SM; Gamal-Eldeen AM; Gouhar SA; Abo-Elfadl MT; El-Saeed G
    Appl Biochem Biotechnol; 2020 Dec; 192(4):1208-1223. PubMed ID: 32710170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.
    Tin AS; Park AH; Sundar SN; Firestone GL
    BMC Biol; 2014 Sep; 12():72. PubMed ID: 25209720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells.
    Chinni SR; Sarkar FH
    Clin Cancer Res; 2002 Apr; 8(4):1228-36. PubMed ID: 11948137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indole-3-carbinol and 3-3'-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions.
    Firestone GL; Bjeldanes LF
    J Nutr; 2003 Jul; 133(7 Suppl):2448S-2455S. PubMed ID: 12840223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
    Rahman KM; Sarkar FH; Banerjee S; Wang Z; Liao DJ; Hong X; Sarkar NH
    Mol Cancer Ther; 2006 Nov; 5(11):2747-56. PubMed ID: 17121921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells.
    Rahman KM; Li Y; Sarkar FH
    Nutr Cancer; 2004; 48(1):84-94. PubMed ID: 15203382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.
    Moiseeva EP; Almeida GM; Jones GD; Manson MM
    Mol Cancer Ther; 2007 Nov; 6(11):3071-9. PubMed ID: 18025290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells.
    Choi HS; Cho MC; Lee HG; Yoon DY
    Food Chem Toxicol; 2010 Mar; 48(3):883-90. PubMed ID: 20060030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.